Euclidean Capital’s Surrozen SRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.82M Hold
87,696
– – 0.87% 7
2026
Q2
$2.28M Hold
87,696
– – 0.52% 9
2026
Q1
$2.55M Hold
87,696
– – 0.65% 8
2025
Q4
$1.98M Hold
87,696
– – 0.54% 10
2025
Q3
$1.13M Hold
87,696
– – 0.47% 10
2025
Q2
$784K Hold
87,696
– – 0.26% 8
2025
Q1
$1.02M Hold
87,696
– – 0.38% 8
2024
Q4
$1.26M Hold
87,696
– – 0.17% 9
2024
Q3
$1.05M Hold
87,696
– – 0.12% 11
2024
Q2
$960K Hold
87,696
– – 0.12% 10
2024
Q1
$1.38M Hold
87,696
– – 0.18% 12
2023
Q4
$824K Sell
87,696
-2
-0% -$14 0.09% 12
2023
Q3
$645K Buy
87,698
+34,167
+64% +$325K 0.14% 12
2023
Q2
$442K Hold
53,531
– – 0.11% 12
2023
Q1
$483K Hold
53,531
– – 0.42% 10
2022
Q4
$467K Hold
53,531
– – 0.44% 11
2022
Q3
$1.62M Hold
53,531
– – 1.51% 10
2022
Q2
$2.41M Hold
53,531
– – 2.05% 10
2022
Q1
$2.42M Hold
53,531
– – 1.4% 11
2021
Q4
$5.17M Hold
53,531
– – 2.94% 8
2021
Q3
$5.68M Buy
+53,531
New +$7.53M 2.76% 8

Other funds holding SRZN

Euclidean Capital's SRZN Position: Q3 2026 in Review

Euclidean Capital held its Surrozen (SRZN) position steady in Q3 2026 at 87,696 shares worth $2.82M. The position accounts for 0.87% of the portfolio, ranked #7.

Euclidean Capital first reported a position in SRZN in Q3 2021 and has held it in 21 quarters since. The position peaked at $5.68M in Q3 2021. 94 funds tracked by Wall St. Rank hold SRZN as of Q3 2026.

  • Euclidean Capital held 87,696 shares of Surrozen worth $2.82M as of Q3 2026.
  • Euclidean Capital left its Surrozen share count unchanged in Q3 2026.
  • Surrozen made up 0.87% of Euclidean Capital's portfolio in Q3 2026, its #7 holding.
  • Euclidean Capital first reported a position in Surrozen in Q3 2021 and has held it in 21 quarters since.
  • Euclidean Capital's Surrozen position peaked at $5.68M in Q3 2021.
  • 94 funds tracked by Wall St. Rank held Surrozen as of Q3 2026.

Based on Euclidean Capital's 13F filing for Q3 2026, filed 16 Nov 2026.